Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine tranexamic acid versus oxytocin gauze for prevention of postpartum hemorrhage after cesarean section
IRCT20260315068990N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of tranexamic acid and oxytocin in postpartum hemorrhage (PPH) (3 arms), sponsored by Kerman University of Medical Sciences. Primary endpoint: Evaluation of bleeding in the first 2 hours after cesarean delivery. Started Mar 2025; status: completed.
02
Drugs
tranexamic acidoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20260315068990N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260315068990N1.